B

PUBLIC MEETING AGENDAS

Committee on Preventing Dementia and Cognitive Impairment

First Committee Meeting
Open Sessions: December 15-16, 2015

National Academy of Sciences Building
2101 Constitution Avenue, NW | Washington, DC 20418

DAY ONE—TUESDAY, DECEMBER 15

DAY TWO—WEDNESDAY, DECEMBER 16

Preventing Dementia and Cognitive Impairment: A Workshop
Open Session: October 25, 2016

National Academy of Sciences Building
2101 Constitution Avenue, NW | Washington, DC 20418

Background: Many organizations and individuals worldwide are interested in the state of the science on preventing Alzheimer’s disease and related dementias, mild cognitive impairment (MCI), and age-related cognitive decline (ARCD). To develop a better understanding of current scientific evidence, implications for public health messaging, and future research needs, the National Institute on Aging (NIA) asked the National Academies of Sciences, Engineering, and Medicine (the National Academies) to convene an expert committee to make recommendations that inform public health strategies and messaging on preventive interventions and recommendations for future research. To aid the committee in its work, NIA has asked the Agency for Healthcare Research and Quality (AHRQ) to commission and oversee a systematic review—conducted by the Minnesota Evidence-based Practice Center (EPC)—of the evidence on interventions associated with preventing, slowing, or delaying the onset of clinical Alzheimer’s-type dementia and MCI, and delaying or slowing ARCD. Other dementias such as frontotemporal dementia, Lewy body dementia, and dementias with a clear etiology, e.g., incident stroke, AIDS, traumatic brain injury will be excluded from the analysis. Interventions targeting stroke risk factors are a priority in this study. To help inform the National Academies committee’s recommendations, this public workshop will bring together key stakeholders to provide input to the committee on the draft AHRQ report. The National Academies committee’s report is expected to be released in June 2017.

Workshop Objectives:

• Collect reactions to the draft EPC systematic review on preventive interventions that might reduce the risk of developing clinical Alzheimer’s-type dementia and mild cognitive impairment, and slow or delay age-related cognitive impairment/decline.
• Explore the current state of evidence on preventive interventions and discuss areas where public health messaging might be warranted.
• Discuss promising, emerging data on interventions that did not meet the evidentiary standard of the systematic review, and identify gaps and areas for future research.

SESSION I: PUBLIC HEALTH MESSAGING AND FUTURE RESEARCH—PERSPECTIVES FROM ACADEMIA

Session Objectives:

• Reflect on the current state of evidence on preventive interventions (not risk factors) and where public health messaging might be warranted.
• Discuss promising, emerging data on interventions that did not meet the evidentiary standard of the systematic review.
• Identify gaps and priorities for future research.

SESSION II: PERSPECTIVES FROM PEOPLE LIVING WITH DEMENTIA, ADVOCACY ORGANIZATIONS, AND PROFESSIONAL SOCIETIES

Session Objectives:

• Comment on which preventive interventions and outcomes are of most interest to people living with dementia and their caregivers.
• Collect input from advocacy organizations and professional societies’ on the EPC draft systematic review, the current state of evidence on preventive interventions and where public health messaging might be warranted, and areas for future research.

Third Committee Meeting
Open Session: January 31, 2017

Meeting Objective:

• Discuss significant changes from the draft to the final AHRQ systematic review, which forms the predominant basis for the work of the National Academies’ Committee on Preventing Dementia and Cognitive Impairment.